TY - JOUR
T1 - Duchenne muscular dystrophy
T2 - Management of difficult airway and concurrent bronchospasm
AU - Pisklakov, Sergey
AU - Chiu, Jason
AU - Le, Vanny
AU - Patel, Anuradha
AU - Tilak, Vasanti
PY - 2012/11
Y1 - 2012/11
N2 - Using succinylcholine and inhalation agents for patients with Duchenne muscular dystrophy is extremely risky. Those risks include heart failure, cardiac dysrhythmias, rhabdomyolysis and malignant hyperthermia. Even in emergent situations, such as intraoperative bronchospasm, succinylcholine and inhalational agents are often considered contraindicated. Nevertheless, if intraoperative bronchospasm does occur in a patient with Duchenne muscular dystrophy, the benefits of using inhalational agents to treat bronchospasm may outweigh the risks in certain situations.
AB - Using succinylcholine and inhalation agents for patients with Duchenne muscular dystrophy is extremely risky. Those risks include heart failure, cardiac dysrhythmias, rhabdomyolysis and malignant hyperthermia. Even in emergent situations, such as intraoperative bronchospasm, succinylcholine and inhalational agents are often considered contraindicated. Nevertheless, if intraoperative bronchospasm does occur in a patient with Duchenne muscular dystrophy, the benefits of using inhalational agents to treat bronchospasm may outweigh the risks in certain situations.
KW - Bronchospasm
KW - Difficult airway management
KW - Duchenne muscular dystrophy
KW - Rhabdomyolysis
KW - Volatile anesthetics
UR - http://www.scopus.com/inward/record.url?scp=84880002231&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84880002231&partnerID=8YFLogxK
U2 - 10.4172/2155-6148.1000262
DO - 10.4172/2155-6148.1000262
M3 - Article
AN - SCOPUS:84880002231
SN - 2155-6148
VL - 3
JO - Journal of Anesthesia and Clinical Research
JF - Journal of Anesthesia and Clinical Research
IS - 11
ER -